Substrate
health

Supreme Court Declines to Hear Pharma Challenges to Medicare Drug Price Program

The U.S. Supreme Court declined to review lawsuits filed by six pharmaceutical companies against the Medicare drug price negotiation program. The White House separately announced an expansion of its TrumpRx discount platform through partnerships with three prescription savings services.

Stat
1 source·May 19, 1:23 PM(10 days ago)·1m read
|
Supreme Court Declines to Hear Pharma Challenges to Medicare Drug Price Programusatoday.com
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

U.S. Supreme Court declined to take up lawsuits filed by six pharmaceutical companies challenging the Medicare drug price negotiation program. The companies that brought the suits were AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Novartis, and Novo Nordisk.

The court provided no reason for its decision. The drugmakers had already lost their appeals in lower courts. The Supreme Court typically does not accept cases when lower courts have reached the same conclusion.

The White House announced an expansion of its TrumpRx prescription drug discount platform. The update adds more than 600 generic drugs to the site. The expansion was arranged through partnerships with Mark Cuban’s Cost Plus Drug Company, Amazon Pharmacy, and GoodRx.

These services already offer drug savings or low-cost prescription medicines. The partnerships address earlier criticism that many brand-name drugs listed on TrumpRx were already available as generics at lower prices. TrumpRx previously offered fewer drugs than the three partner services.

Key Facts

Supreme Court decision
Declined to hear six company lawsuits on Medicare pricing
Companies involved
AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Novartis, Novo Nordisk
TrumpRx expansion
Added more than 600 generic drugs via three partnerships

Potential Impact

  1. 01

    Patients may access additional generic drugs through the TrumpRx platform.

  2. 02

    Drug companies may face greater difficulty pursuing remaining legal challenges to the Medicare pricing program.

Transparency Panel

Sources cross-referenced1
Confidence score75%
Synthesized bySubstrate AI
Word count159 words
PublishedMay 19, 2026, 1:23 PM
Bias signals removed2 across 1 outlet
Signal Breakdown
Loaded 1Framing 1

Related Stories

Zambia’s Kabwe Residents Sue Mining Company Over Lead ContaminationFrance 24
health5 hrs agoDeveloping

Zambia’s Kabwe Residents Sue Mining Company Over Lead Contamination

Children in Kabwe, Zambia, show blood lead levels above World Health Organization limits after decades of mining. An estimated 140,000 women and children have joined a class-action lawsuit against Anglo American South Africa Limited.

France 24
FR
2 sources
Ebola Outbreak in Eastern DRC Kills at Least 240 Since Early Maycitizen.co.za
health11 hrs ago

Ebola Outbreak in Eastern DRC Kills at Least 240 Since Early May

The virus has spread from Ituri province into other eastern DRC regions and Uganda. Health workers report reduced international aid and limited local resources as they attempt to contain transmission.

The Guardian
1 source
Outbreaks of hantavirus and Ebola prompt U.S. quarantine and travel measuresmanilatimes.net
health9 hrs ago

Outbreaks of hantavirus and Ebola prompt U.S. quarantine and travel measures

The U.S. government ordered quarantines after a hantavirus outbreak on a cruise ship and imposed new traveler restrictions during an Ebola outbreak in Africa. Federal agencies stated that response operations continue despite recent staffing reductions at health agencies.

Cbs News
1 source